A healthy dietary pattern associates with a lower risk of a first clinical diagnosis of central nervous system demyelination

A healthy dietary pattern associates with a lower risk of a first clinical diagnosis of central nervous system demyelination

<p><strong>Background:</strong></p> <p>The evidence associating diet and risk of multiple sclerosis is inconclusive.</p> <p><strong>Objective:</strong></p> <p>We investigated associations between dietary patterns and risk of a first...

Descripció completa

Dades bibliogràfiques
Autors principals:	Ausimmune Investigator Group, Black, LJ, Rowley, C, Sherriff, J, Pereira, G, Ponsonby, A-L, Lucas, RM
Altres autors:	Dwyer, T
Format:	Journal article
Idioma:	English
Publicat:	SAGE Publications 2018

Ítems similars

Reported changes in dietary behavior following a first clinical diagnosis of central nervous system demyelination
per: Russell, R, et al.
Publicat: (2018)

Higher fish consumption and lower risk of central nervous system demyelination
per: Black, L, et al.
Publicat: (2019)

A higher Mediterranean diet score, including unprocessed red meat, is associated with reduced risk of central nervous system demyelination in a case-control study of Australian adults
per: Black, LJ, et al.
Publicat: (2019)

Higher Non-processed Red Meat Consumption Is Associated With a Reduced Risk of Central Nervous System Demyelination
per: Black, L, et al.
Publicat: (2019)

Higher tinned fish intake associates with a lower risk of a first clinical diagnosis of central nervous system demyelination
per: L.J. Black, et al.
Publicat: (2017-06-01)

Stressful life events and the risk of initial central nervous system demyelination
per: Saul, A, et al.
Publicat: (2017)

A novel approach for prediction of vitamin d status using support vector regression.
per: Shuyu Guo, et al.
Publicat: (2013-01-01)

Total Dairy Consumption Is Not Associated With Likelihood of a First Clinical Diagnosis of Central Nervous System Demyelination
per: Dao Ying Rachel Dieu, et al.
Publicat: (2022-05-01)

Demyelinating Disease? Central Nervous System Lymphoma?
per: Ufuk Ergün, et al.
Publicat: (2008-06-01)

Analytical Bias in the Measurement of Serum 25-Hydroxyvitamin D Concentrations Impairs Assessment of Vitamin D Status in Clinical and Research Settings.
per: Lucinda J Black, et al.
Publicat: (2015-01-01)

Olfactory Pathology in Central Nervous System Demyelinating Diseases.
per: DeLuca, G, et al.
Publicat: (2014)

Severe central nervous system demyelination in Sanfilippo disease
per: Mahsa Taherzadeh, et al.
Publicat: (2023-12-01)

Spectrum of acute central nervous system demyelinating diseases
per: Bharathkanth Reddy M1 , Ranjith Kumar P2 , P.L John Israel3
Publicat: (2017-04-01)

The role of interleukin-6 in central nervous system demyelination
per: Filip Petkovic, et al.
Publicat: (2016-01-01)

Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study
per: Hoare, S, et al.
Publicat: (2015)

Case report: Chronic inflammatory demyelinating polyradiculoneuropathy with severe central nervous system demyelination: a clinicopathological study
per: Goichi Beck, et al.
Publicat: (2024-12-01)

Psychiatric disorders in children with demyelinating diseases of the central nervous system
per: Pakpoor, J, et al.
Publicat: (2017)

Application of metabolomics in inflammatory demyelinating diseases of the central nervous system
per: Yeo, T
Publicat: (2020)

Auto antibodies in inflammatory demyelinating diseases of the central nervous system
per: Swiss Medical Weekly
Publicat: (2008-11-01)

Optical coherent tomography capabilities in the diagnosis of demyelinating diseases of the central nervous system
per: Natalia V. Polekhina, et al.
Publicat: (2018-10-01)

Optical coherence tomography in central nervous system demyelinating diseases related optic neuritis
per: Nattapong Mekhasingharak, et al.
Publicat: (2018-10-01)

Acquired demyelinating disorders of the central nervous system in a sample of Egyptian children
per: Mohamed Ahmed, et al.
Publicat: (2025-03-01)

Demyelinating sentinel lesion preceding a primary central nervous system lymphoma
per: Flávia Sprenger, et al.
Publicat: (2021-11-01)

Acute combined central and peripheral nervous system demyelination: a case report
per: Young Eun Roh, et al.
Publicat: (2018-12-01)

Central nervous system Cryptococcoma mimicking demyelinating disease: a case report
per: Jie Wei, et al.
Publicat: (2020-08-01)

Central nervous system Listeria monocytogenes infection mimicking central nervous system idiopathic inflammatory demyelinating disease
per: Xu R, et al.
Publicat: (2019-01-01)

Neuroborreliosis mimicking demyelinating disease of the central nervous system: case reports
per: N. Giedraitienė, et al.
Publicat: (2018-09-01)

The Roles of Caloric Restriction Mimetics in Central Nervous System Demyelination and Remyelination
per: Despoina Kaffe, et al.
Publicat: (2023-11-01)

Characteristics of hypersomnia due to inflammatory demyelinating diseases of the central nervous system
per: Keiko Tanaka, et al.
Publicat: (2023-01-01)

Central nervous system demyelinating diseases: glial cells at the hub of pathology
per: Vinicius Gabriel Coutinho Costa, et al.
Publicat: (2023-05-01)

Pregnancy-Related Immune Changes and Demyelinating Diseases of the Central Nervous System
per: Ke Qiu, et al.
Publicat: (2019-10-01)

Insights into Initial Demyelinating Episodes of Central Nervous System during Puerperium
per: Qian Wu, et al.
Publicat: (2017-01-01)

Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system
per: Jing Zhang, et al.
Publicat: (2016-04-01)

Corrigendum: Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System
Publicat: (2017-01-01)

Central nervous system demyelination associated with Etanercept in a 51 year old woman
per: Dirik Dileu, et al.
Publicat: (2007-03-01)

Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient
per: Christos Koros, et al.
Publicat: (2013-01-01)

Identification of potential functional peptides involved in demyelinating injury in the central nervous system
per: Xiaohua Dong, et al.
Publicat: (2023-08-01)

The role and potential therapeutic targets of astrocytes in central nervous system demyelinating diseases
per: Rui Tan, et al.
Publicat: (2023-09-01)

Anti-IL-6 therapies in central nervous system inflammatory demyelinating diseases
per: Li Jiao, et al.
Publicat: (2022-10-01)

Diagnostic value of NMO-IgG in demyelinating diseases of central nervous system
per: Xiao-min XU, et al.
Publicat: (2016-09-01)